140 related articles for article (PubMed ID: 36087218)
1. Sex differences in COVID-19 symptoms and outcomes in people with kidney failure treated with dialysis: a prospective cohort study.
Harrison TG; Tam TA; Elliott MJ; Ahmed SB; Riehl-Tonn V; Swamy AKR; Benham JL; Peterson J; MacRae JM
J Nephrol; 2023 Apr; 36(3):851-860. PubMed ID: 36087218
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 Status, Symptom Burden, and Characteristics of Dialysis Patients Residing in Areas of Community Transmission: Research Letter.
Gale J; Clark DA; Bohm C; Canney M; Davis I; LeBlanc JJ; Shorter AM; Suri RS; Vinson AJ; West KA; Tennankore KK
Can J Kidney Health Dis; 2020; 7():2054358120964178. PubMed ID: 33117550
[TBL] [Abstract][Full Text] [Related]
3. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
4. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
5. Clinical and epidemiological aspects of SARS-CoV-2 infection among pregnant and postpartum women in Mozambique: a prospective cohort study.
Charles CM; Osman NB; Arijama D; Matingane B; Sitoé T; Kenga D; Lorenzoni C; Luís E; Pacagnella RC; Sacarlal J;
Reprod Health; 2022 Jul; 19(1):164. PubMed ID: 35854384
[TBL] [Abstract][Full Text] [Related]
6. Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
Lund LC; Kristensen KB; Reilev M; Christensen S; Thomsen RW; Christiansen CF; Støvring H; Johansen NB; Brun NC; Hallas J; Pottegård A
PLoS Med; 2020 Sep; 17(9):e1003308. PubMed ID: 32898149
[TBL] [Abstract][Full Text] [Related]
7. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086
[TBL] [Abstract][Full Text] [Related]
8. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Vaccine Effectiveness and Breakthrough Infections Among Patients Receiving Maintenance Dialysis.
Manley HJ; Li NC; Aweh GN; Hsu CM; Weiner DE; Miskulin D; Harford AM; Johnson D; Lacson E
Am J Kidney Dis; 2023 Apr; 81(4):406-415. PubMed ID: 36462570
[TBL] [Abstract][Full Text] [Related]
10. Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK.
Makaronidis J; Firman C; Magee CG; Mok J; Balogun N; Lechner M; Carnemolla A; Batterham RL
BMC Infect Dis; 2021 Feb; 21(1):221. PubMed ID: 33632171
[TBL] [Abstract][Full Text] [Related]
11. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews.
Karaarslan F; Demircioğlu Güneri F; Kardeş S
Rheumatol Int; 2021 Jul; 41(7):1263-1271. PubMed ID: 33978818
[TBL] [Abstract][Full Text] [Related]
12. Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients.
Broseta JJ; Rodríguez-Espinosa D; Rodríguez N; Mosquera MDM; Marcos MÁ; Egri N; Pascal M; Soruco E; Bedini JL; Bayés B; Maduell F
Am J Kidney Dis; 2021 Oct; 78(4):571-581. PubMed ID: 34174364
[TBL] [Abstract][Full Text] [Related]
13. Association between Chronic Kidney Disease or Acute Kidney Injury and Clinical Outcomes in COVID-19 Patients.
Kang SH; Kim SW; Kim AY; Cho KH; Park JW; Do JY
J Korean Med Sci; 2020 Dec; 35(50):e434. PubMed ID: 33372426
[TBL] [Abstract][Full Text] [Related]
14. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
15. [Clinical Characteristics of Mild-Moderate COVID-19 Patients and Risk Factors for the Development of Pneumonia].
Özdemir YE; Balkan İİ; Bayramlar OF; Alkan S; Murt A; Karaali R; Mete B; Kuşkucu MA; Aygün G; Keskindemirci Y; Öngören Ş; Kutlubay Z; Çetinkale O; Saltoğlu N; Tabak F
Mikrobiyol Bul; 2021 Jul; 55(3):342-356. PubMed ID: 34416801
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider.
Hsu CM; Weiner DE; Aweh G; Miskulin DC; Manley HJ; Stewart C; Ladik V; Hosford J; Lacson EC; Johnson DS; Lacson E
Am J Kidney Dis; 2021 May; 77(5):748-756.e1. PubMed ID: 33465417
[TBL] [Abstract][Full Text] [Related]
17. Predictors of chronic COVID-19 symptoms in a community-based cohort of adults.
Silverberg JI; Zyskind I; Naiditch H; Zimmerman J; Glatt AE; Pinter A; Theel ES; Joyner MJ; Hill DA; Lieberman MR; Bigajer E; Stok D; Frank E; Rosenberg AZ
PLoS One; 2022; 17(8):e0271310. PubMed ID: 35925904
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2.
Wohl DA; Barzin AH; Napravnik S; Davy-Mendez T; Smedberg JR; Thompson CM; Ruegsegger L; Gilleskie M; Weber DJ; Whinna HC; Miller MB
PLoS One; 2021; 16(12):e0260879. PubMed ID: 34890441
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods.
Marquez C; Kerkhoff AD; Schrom J; Rojas S; Black D; Mitchell A; Wang CY; Pilarowski G; Ribeiro S; Jones D; Payan J; Manganelli S; Rojas S; Lemus J; Jain V; Chamie G; Tulier-Laiwa V; Petersen M; DeRisi J; Havlir DV
JAMA Netw Open; 2022 Oct; 5(10):e2235844. PubMed ID: 36215069
[TBL] [Abstract][Full Text] [Related]
20. Mortality and associated risk factors of COVID-19 infection in dialysis patients in Qatar: A nationwide cohort study.
Ghonimi TAL; Alkad MM; Abuhelaiqa EA; Othman MM; Elgaali MA; Ibrahim RAM; Joseph SM; Al-Malki HA; Hamad AI
PLoS One; 2021; 16(7):e0254246. PubMed ID: 34293004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]